ArticleBJS open2025
Development and validation of a short version of the MD Anderson Symptom Inventory for upper gastrointestinal surgery (short-MDASI-UGI-Surg) for postoperative patient-reported outcome-based care.
Article in BJS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ASO Author Reflections: What is "Recovery"? Lessons from Patient-Reported Outcomes in Gastrectomy.Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
backgroundThe MD Anderson Symptom Inventory for upper gastrointestinal surgery (MDASI-UGI-Surg) is a validated 27-item patient-reported outcome instrument designed to assess perioperative symptom burden and functional status in patients undergoing surgery for upper gastrointestinal cancers. This study aimed to develop a shortened version (Short-MDASI-UGI-Surg) that preserves the sensitivity of the original tool while reducing respondent burden.
methodsProspectively collected longitudinal patient-reported outcome data obtained using the MDASI-UGI-Surg or the MDASI in patients with gastrointestinal cancer (MDASI-GI) from patients who underwent oesophagectomy, gastrectomy, or pancreatectomy for cancer were retrospectively analysed. Symptom severity and temporal patterns were examined using hierarchical clustering, and representative symptoms were selected based on clinical relevance and symptom severity through correlation analysis.
resultsTime series clustering of the 27 items collected from 302 patients revealed three distinct symptom/interference clusters based on relative peak timing: acute, with items peaking on postoperative day (POD) 3; subacute, peaking on POD 21; and persistent, extending through postoperative months 3-6. Within each symptom/interference cluster, items were identified that were highly correlated with other items (r ≥ 0.55), from which 13 representative symptom or interference items were selected. The 13 selected items were incorporated into the Short-MDASI-UGI-Surg and demonstrated high concurrent validity with the harmonized full MDASI reference (r = 0.98) and strong concordance in time series trends across all timepoints (r = 0.96-0.98). Known groups validity was supported by significant differences in scores between the oesophagectomy, pancreatectomy, and gastrectomy groups using both the harmonized full MDASI instrument and the Short-MDASI-UGI-Surg.
conclusionsThe 13-item Short-MDASI-UGI-Surg, may reduce respondent burden and enhance clinical implementation while promoting patient engagement in perioperative symptom monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.